Uncategorised - European Medical Journal

EBMT Jon J. Van Rood Award Winner 2026: Julius Fischer

Julius Fischer. Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University…

HFpEF in Hypertrophic Cardiomyopathy Predicts Poor Outcomes

Model interpretability analysis identified HFpEF status and B-type natriuretic peptide (BNP) levels as the most influential predictors of adverse outcomes.

ESCMID 2026: Expert Calls for Responsible AI Use Amid AMR Crisis

Rasha Elshenawy highlighted the promise of AI in antimicrobial stewardship but warned that use must be responsible in exclusive insight from ESCMID Global 2026.

Distressed woman sitting at home.

Hormonal Shifts May Redefine Sjogren’s Disease Risk

Hormonal transitions across the lifespan may reshape sex differences in Sjogren’s disease risk and prevalence patterns.

Urban Living Linked to More Severe EoE Phenotype

Urban residency is associated with more severe allergic features and inflammation in eosinophilic esophagitis, new research shows.

Catalyst of Pharma - Andrew Menzies-Gow

AZ’s Andrew Menzies-Gow on a new era for respiratory care

In this interview, Andrew Menzies-Gow, AstraZeneca, explores how earlier diagnosis could transform respiratory care.

Toripalimab JUPITER-02 and -06 data

Updated clinical data from the Phase III JUPITER-02 and JUPITER-06 trials of the anti-PD1 antibody toripalimab in NPC and OSCC, presented…

Transgender Cancer Care Discrimination Linked to Poorer Outcomes

Cancer care discrimination is more common in transgender and non-binary patients and is linked to poorer self-reported health outcomes.

Moderna initiates phase 3 bird flu vaccine trial

A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated.

Patient using a walker with clinician support during a mobility assessment in a medical setting

AAN 2026: CAR-T Therapy Shows Promise in Stiff Person Syndrome

CAR-T therapy improved mobility and stiffness in stiff person syndrome in a pivotal Phase II study.